(Finance) –
“Today the export of Made in Italy companies in the biotech sector is over 16 billion eurosup 45% compared to 2019. The first half of 2024 was also positive, standing at 8.5 billion euros, up by almost 10% compared to the same period of the previous year. The most developed sector is that relating to “life science”, but great strides have been made in recent years by biotechnology applied to the agricultural, food and industrial sectors. Important values with high potential to promote the development of innovation, also for the purposes of the circular and regenerative economy”. Thus Matteo ZoppasPresident of ICE, at the presentation of the Interim report of the working group for the internationalization of companies in the biotechnology sector.
“Foreign Minister Antonio Tajani did well to underline the substantial contribution of the country system in the field of growth diplomacy. We as ICE brings companies to some of the main international events in the sector such as IFIB Bio Europe; European Summit of Industrial Biotechnology; JP Morgan Healthcare Conference Arab Health; Swiss Biotech Days; Bio Korea and BIO USA. Initiatives that aim to strengthen the presence of our companies and Italian DNA in key markets, such as Europe (UK, Germany and France) and the USA, but also in emerging markets. These include Qatar, where the biotech sector is considered to be on the rise, Chile, Malaysia which considers biotechnology and life (and health) sciences among the key sectors for the growth of its manufacturing industry and Hong Kong which has the highest life expectancy in the world, thanks to its advanced healthcare services.
“In this context, another important factor is the ability to attract foreign investments in Italy. In this sector, relationships involving B2G and G2G channels can also play a decisive role. As later declared by the Minister of Health Orazio Schillaci, the acceleration that Artificial Intelligence is bringing to this sector brings the issue of speed to the foreground even in the promotion of companies abroad. This is why it is important to close the ranks of all the institutional actors involved, in order to support this internationalization process.”